psychiatrist, but is not board-certified in any specialty. He was employed as a medical
director at Facility A from October 2014 through October 2015; at Facility B from August
2015 through February 2017; and at Facility C from January 3, 2017 until September
18, 2017.

On April 26, 2016, the Board received a complaint from two social workers
employed by Facility B alleging that Dr. Rajaratnam had recommended that a former
patient share her prescription of Seroquel, an antipsychotic medication, with her minor
son. The Board opened an investigation. As part of the investigation, the Board
obtained a written response from Dr. Rajaratnam and subpoenaed his personnel and
medical files. The Board also interviewed Dr. Rajaratnam and several witnesses. Also
as part of the investigation, Panel A ordered that Dr. Rajaratnam be evaluated by
MPRP. MPRP met with Dr. Rajaratnam and referred him to a psychologist for an
evaluation, under Md. Code Ann., Health Occ. § 14-402. The psychologist
recommended that Dr. Rajaratnam discontinue the practice of medicine. Following that
report, Disciplinary Panel A voted to summarily suspend Dr. Rajaratnam’s medical
license, pursuant to Md. Code Ann., State Gov't § 10-226(c)(2)(i), concluding that the
public health safety, or welfare imperatively required emergency action. Panel A also
voted to charge Dr. Rajaratnam under the Maryland Medical Practice Act, Md. Code
Ann., Health Occ. Il § 14-404(a)(4), as “professionally, physically, or mentally
incompetent.”

On October 10, 2017, prior to the issuance of the Order of Summary Suspension
and disciplinary charges, Dr. Rajaratnam entered into a Consent Order with Panel A,

which concluded as a matter of law that the public health, safety or welfare imperatively
